(Q43812097)

27 November 2017

Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin). (English)

1 reference

27 November 2017

0 references

1 reference

coronary artery disease

1 reference

Masumoto A

1

1 reference

27 November 2017

Hirooka Y

2

1 reference

27 November 2017

Hironaga K

3

1 reference

27 November 2017

Eshima K

4

1 reference

27 November 2017

Setoguchi S

5

1 reference

27 November 2017

Egashira K

6

1 reference

27 November 2017

Takeshita A

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

American Journal of Cardiology

27 November 2017

1 reference

27 November 2017

88

1 reference

27 November 2017

11

1 reference

27 November 2017

1291-1294

1 reference

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902090-2

Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902090-2

Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902090-2

Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902090-2

Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902090-2

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902090-2

Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902090-2

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902090-2

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902090-2

Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902090-2

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902090-2

Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902090-2

10.1016/S0002-9149(01)02090-2

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference